欧洲药品管理局推荐批准Alvotech公司Gobivaz®的营销许可,该产品为Simponi® (戈利木单抗)的拟议生物类似药,Advanz Pharma作为商业化合作伙伴。
欧洲药品管理局推荐批准Alvotech公司Gobivaz®的营销许可,该产品为Simponi® (戈利木单抗)的拟议生物类似药,Advanz Pharma作为商业化合作伙伴。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.